EMEA regulation News
Most Popular EMEA regulation Story
EMEA: Raptiva PML risks outweigh benefits
Sobering news on Genentech's psoriasis med Raptiva: Another case of the rare brain disease PML (progressive multifocal leukocephalopathy) has cropped up in a patient using the drug, marketed in Read more...
Latest Headlines
- February 20, 2009
- December 12, 2008
- December 11, 2008
- October 27, 2008
- October 9, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
